ipRGCs as Early Biomarkers for Neurodegenerative Disease Detection
Groundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read moreGroundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read moreParkinson’s disease (PD) is a progressive neurodegenerative condition impacting millions globally. While a blend of genetic, environmental, and ageing factors
Read moreVentus Therapeutics, a US-based clinical-stage biopharmaceutical company leveraging its exclusive structural biology and computational chemistry platform, ReSOLVE™, has disclosed promising
Read moreAbbVie has introduced PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union to address advanced Parkinson’s disease. AbbVie (NYSE: ABBV) recently announced the
Read moreAlzheimer’s disease (AD) and Parkinson’s disease (PD) stand as the two most prevalent neurodegenerative disorders, each characterized by the cerebral
Read moreStressMarq Biosciences, a pioneer in the development and commercialization of unique fibrilized and oligomeric protein preparations to propel the study
Read moreA collaboration between StressMarq Biosciences and Gubra has generated a 3D whole-brain light sheet fluorescence imaging model depicting alpha-synuclein pSer129+
Read moreStressMarq manufactures and offers a wide range of products specifically developed to accelerate Parkinson’s disease research. StressMarq’s cutting-edge product range
Read moreStressMarq has developed unique Superoxide Dismutase 1 (SOD1) Pre-formed Fibrils (PFFs) and monomers for neurodegenerative disease research, particularly valuable for
Read moreStressMarq has developed unique Transthyretin (TTR) Filaments and Monomers designed to propel research on TTR and its association with amyloid
Read more